Literature DB >> 20453311

Investigation of the 22q11.2 candidate region in patients with midline facial defects with hypertelorism.

M Simioni1, E Lopes Freitas, T Paiva Vieira, I Lopes-Cendes, V Lúcia Gil-da-Silva-Lopes.   

Abstract

Midline facial defects with hypertelorism (MFDH) are mainly characterized by ocular hypertelorism and bifid nose. They are often associated with structural and functional anomalies of the central nervous system similar to those found in 22q11.2 deletion syndromes. In addition, there are some isolated reports of MFDH and 22q11.2 deletion. These findings suggest that MFDH may be part of the spectrum of 22q11.2 deletion syndromes. To test this hypothesis, 10 individuals with MFDH were analyzed by fluorescent in situ hybridization (FISH), but no 22q11.2 deletion was detected. In view of this result, the TBX1 gene located within the 22q11.2 candidate region was screened. A new sequence variant (1132GA) was identified in one patient. This variant was not found in 110 control individuals genotyped. Considering the rarity of this condition and results of this study, the involvement of the 22q11.2 chromosomal region in the pathogenesis of MFDH could not be excluded.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453311     DOI: 10.1007/BF03195732

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  13 in total

1.  Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients.

Authors:  A Rauch; K Devriendt; A Koch; R Rauch; M Gewillig; C Kraus; M Weyand; H Singer; A Reis; M Hofbeck
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

2.  Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study.

Authors:  Tony J Simon; Lijun Ding; Joel P Bish; Donna M McDonald-McGinn; Elaine H Zackai; James Gee
Journal:  Neuroimage       Date:  2005-01-08       Impact factor: 6.556

3.  Cerebellar involvement in midline facial defects with ocular hypertelorism.

Authors:  Silvyo David Araújo Giffoni; Vanda Maria Gimenes Gonçalves; Verônica Araújo Zanardi; Vera Lucia Gil-da-Silva-Lopes
Journal:  Cleft Palate Craniofac J       Date:  2006-07

4.  Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.

Authors:  Christiane Zweier; Heinrich Sticht; Inci Aydin-Yaylagül; Christine E Campbell; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

5.  A clinical study of 31 individuals with midline facial defects with hypertelorism and a guideline for follow-up.

Authors:  Vera Lúcia Gil-da-Silva-Lopes; Andréa Trevas Maciel-Guerra
Journal:  Arq Neuropsiquiatr       Date:  2007-06       Impact factor: 1.420

6.  Frontonasal malformation and deletion of 22q11.

Authors:  S J Kirkpatrick; R M Pauli
Journal:  Am J Med Genet       Date:  1998-02-03

7.  Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study.

Authors:  Linda E Campbell; Eileen Daly; Fiona Toal; Angela Stevens; Rayna Azuma; Marco Catani; Virginia Ng; Therese van Amelsvoort; Xavier Chitnis; William Cutter; Declan G M Murphy; Kieran C Murphy
Journal:  Brain       Date:  2006-03-28       Impact factor: 13.501

8.  Tbx1 is expressed at multiple sites of epithelial-mesenchymal interaction during early development of the facial complex.

Authors:  Maria Zoupa; Maisa Seppala; Thimios Mitsiadis; Martyn T Cobourne
Journal:  Int J Dev Biol       Date:  2006       Impact factor: 2.203

9.  Frontonasal malformation with tetralogy of Fallot associated with a submicroscopic deletion of 22q11.

Authors:  R F Stratton; R M Payne
Journal:  Am J Med Genet       Date:  1997-03-31

10.  Role of TBX1 in human del22q11.2 syndrome.

Authors:  Hisato Yagi; Yoshiyuki Furutani; Hiromichi Hamada; Takashi Sasaki; Shuichi Asakawa; Shinsei Minoshima; Fukiko Ichida; Kunitaka Joo; Misa Kimura; Shin-ichiro Imamura; Naoyuki Kamatani; Kazuo Momma; Atsuyoshi Takao; Makoto Nakazawa; Nobuyoshi Shimizu; Rumiko Matsuoka
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

View more
  1 in total

1.  Maternally inherited partial monosomy 9p (pter → p24.1) and partial trisomy 20p (pter → p12.1) characterized by microarray comparative genomic hybridization.

Authors:  Érika L Freitas; Susan M Gribble; Milena Simioni; Társis P Vieira; Roseane L Silva-Grecco; Marly A S Balarin; Elena Prigmore; Ana C Krepischi-Santos; Carla Rosenberg; Karoly Szuhai; Arie van Haeringen; Nigel P Carter; Vera Lúcia Gil-da-Silva-Lopes
Journal:  Am J Med Genet A       Date:  2011-09-21       Impact factor: 2.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.